IEX •
Healthcare •
Biotechnology •
Quote as of 05/28/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization70.43 mln
Float410 mln
Earnings Date08/11/2026
Piotroski F-Score
1
/ 9
Very weak
Beneish M-Score
-3.15
Reliable
Relative Strength
99
/ 100
Top performer
Debt / Equity
-1.02
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Sangamo Therapeutics is a California-based medical research company working to develop gene-based treatments for serious and life-altering diseases. Its most advanced programs are targeting conditions such as Fabry disease, hemophilia A, and kidney transplant rejection, with several treatments currently in clinical trials. The company works alongside major pharmaceutical partners including Pfizer, Sanofi, Biogen, and Novartis to advance its pipeline, while also exploring early-stage research into neurological conditions such as Huntington's disease and ALS.
